EQS-News: Formycon AG / Key word (s): Regulatory Approval Formycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE® ...
In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price ...
Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.
23h
GlobalData on MSNTeva and Alvotech launch ustekinumab biosimilar injection in USTeva Pharmaceuticals and Alvotech have announced the US launch of the Selarsdi (ustekinumab-aekn) injection, a biosimilar to ...
17h
DPReview on MSNSigma's also announced a brand new lookSigma has had a busy day. It's unveiled a new visual identity for its brand, alongside announcements of a new mirrorless ...
Bloomberg's Caroline Hyde and Jackie Davalos break down Apple's $500 billion investment in the US and the company's plans to boost hiring as it seeks relief from President Trump's tariffs.
23h
Nofilmschool on MSNCheck Out Sigma’s New Brand IdentitySince being founded back in 1961, Sigma has made a name for itself in the film and video space with its great cameras and ...
Far-left activist journalist Joy Reid has finally been shown the door by MSNBC after appearing on the liberal network since 2011. In that time she amassed an impressive collection of cringe ...
Please note that the Company executives will be participating in the Institutional Investors'' Meeting - IIFL Global Investors Conference on February 26, 2025 at Mumbai. It is expected that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results